| A breaker of advanced glycation end products attenuates diabetes-induced myocardial structural changes R Candido, JM Forbes, MC Thomas, V Thallas, RG Dean, WC Burns, ... Circulation research 92 (7), 785-792, 2003 | 638 | 2003 |
| Diabetic cardiomyopathy: mechanisms and new treatment strategies targeting antioxidant signaling pathways K Huynh, BC Bernardo, JR McMullen, RH Ritchie Pharmacology & therapeutics 142 (3), 375-415, 2014 | 616 | 2014 |
| Androgen receptors mediate hypertrophy in cardiac myocytes JD Marsh, MH Lehmann, RH Ritchie, JK Gwathmey, GE Green, ... Circulation 98 (3), 256-261, 1998 | 522 | 1998 |
| Basic mechanisms of diabetic heart disease RH Ritchie, ED Abel Circulation Research 126 (11), 1501-1525, 2020 | 369 | 2020 |
| Implications of underlying mechanisms for the recognition and management of diabetic cardiomyopathy TH Marwick, R Ritchie, JE Shaw, D Kaye Journal of the American College of Cardiology 71 (3), 339-351, 2018 | 307 | 2018 |
| Nitroxyl (HNO): the Cinderella of the nitric oxide story JC Irvine, RH Ritchie, JL Favaloro, KL Andrews, RE Widdop, ... Trends in Pharmacological Sciences 29 (12), 601-608, 2008 | 301 | 2008 |
| Myocardial autophagy activation and suppressed survival signaling is associated with insulin resistance in fructose-fed mice KM Mellor, JR Bell, MJ Young, RH Ritchie, LMD Delbridge Journal of molecular and cellular cardiology 50 (6), 1035-1043, 2011 | 221 | 2011 |
| Oxidative stress and NLRP3-inflammasome activity as significant drivers of diabetic cardiovascular complications: therapeutic implications A Sharma, M Tate, G Mathew, JE Vince, RH Ritchie, JB De Haan Frontiers in physiology 9, 331431, 2018 | 183 | 2018 |
| Coenzyme Q10 attenuates diastolic dysfunction, cardiomyocyte hypertrophy and cardiac fibrosis in the db/db mouse model of type 2 diabetes K Huynh, H Kiriazis, XJ Du, JE Love, KA Jandeleit-Dahm, JM Forbes, ... Diabetologia 55, 1544-1553, 2012 | 166 | 2012 |
| Cardiac-specific IGF-1 receptor transgenic expression protects against cardiac fibrosis and diastolic dysfunction in a mouse model of diabetic cardiomyopathy K Huynh, JR McMullen, TL Julius, JW Tan, JE Love, N Cemerlang, ... Diabetes 59 (6), 1512-1520, 2010 | 165 | 2010 |
| Targeting the upregulation of reactive oxygen species subsequent to hyperglycemia prevents type 1 diabetic cardiomyopathy in mice K Huynh, H Kiriazis, XJ Du, JE Love, SP Gray, KA Jandeleit-Dahm, ... Free Radical Biology and Medicine 60, 307-317, 2013 | 163 | 2013 |
| Antihypertrophic actions of the natriuretic peptides in adult rat cardiomyocytes: importance of cyclic GMP AC Rosenkranz, RL Woods, GJ Dusting, RH Ritchie Cardiovascular research 57 (2), 515-522, 2003 | 161 | 2003 |
| Non-alcoholic steatohepatitis: a review of its mechanism, models and medical treatments C Peng, AG Stewart, OL Woodman, RH Ritchie, CX Qin Frontiers in Pharmacology 11, 603926, 2020 | 153 | 2020 |
| Angiotensin II-induced hypertrophy of adult rat cardiomyocytes is blocked by nitric oxide RH Ritchie, RJ Schiebinger, MC Lapointe, JD Marsh American Journal of Physiology-Heart and Circulatory Physiology 275 (4 …, 1998 | 146 | 1998 |
| Ubiquinone (coenzyme Q10) prevents renal mitochondrial dysfunction in an experimental model of type 2 diabetes KC Sourris, BE Harcourt, PH Tang, AL Morley, K Huynh, SA Penfold, ... Free Radical Biology and Medicine 52 (3), 716-723, 2012 | 145 | 2012 |
| Myocardial oxidative stress contributes to transgenic β2‐adrenoceptor activation‐induced cardiomyopathy and heart failure Q Xu, A Dalic, L Fang, H Kiriazis, RH Ritchie, K Sim, XM Gao, ... British journal of pharmacology 162 (5), 1012-1028, 2011 | 132 | 2011 |
| Antioxidant actions contribute to the antihypertrophic effects of atrial natriuretic peptide in neonatal rat cardiomyocytes A Laskowski, OL Woodman, AH Cao, GR Drummond, T Marshall, ... Cardiovascular Research 72 (1), 112-123, 2006 | 117 | 2006 |
| Small-molecule-biased formyl peptide receptor agonist compound 17b protects against myocardial ischaemia-reperfusion injury in mice CX Qin, LT May, R Li, N Cao, S Rosli, M Deo, AE Alexander, D Horlock, ... Nature Communications 8 (1), 14232, 2017 | 110 | 2017 |
| Novel role for the AnxA1-Fpr2/ALX signaling axis as a key regulator of platelet function to promote resolution of inflammation EY Senchenkova, J Ansari, F Becker, SA Vital, Z Al-Yafeai, ... Circulation 140 (4), 319-335, 2019 | 108 | 2019 |
| Are targeted therapies for diabetic cardiomyopathy on the horizon? M Tate, DJ Grieve, RH Ritchie Clinical Science 131 (10), 897-915, 2017 | 105 | 2017 |
